Lynparza 150 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KL5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $103,471
Award facts
- Contract value 100% obligated
- $103,471.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $103,471.40 by the Defense Logistics Agency on January 9, 2026, for the supply of Lynparza 150 mg tablets (120 count). This is a firm fixed-price, non-competitive set-aside contract with an ultimate completion date of February 2, 2026. The award leverages Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $1 billion pharmaceutical prime vendor vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
As the child entity of parent company Cencora, Inc. (doing business as Amerisourcebergen), Amerisourcebergen Drug Corp maintains a critical position in the federal pharmaceutical supply chain. The DLA Medical Supply Chain relies on this vendor to deliver specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains to military treatment facilities, the Defense Health Agency, and other federal healthcare systems. This delivery order for Lynparza, an oncology medication, represents a routine fulfillment under the larger pharmaceutical prime vendor framework that has demonstrated the company's capability to meet federal procurement requirements through competitive award processes.
Quick answers
Who was awarded contract SPE2DR26F9KL5?
SPE2DR26F9KL5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9KL5 worth?
The government has obligated $103,471 on SPE2DR26F9KL5.
Is contract SPE2DR26F9KL5 an order under another contract?
Yes. SPE2DR26F9KL5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KL5 competed?
The extent of competition for SPE2DR26F9KL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award